GENSULIN N

Indications

• Immunotherapy for cancer
• Replacement therapy for hormonal deficiencies
• Treatment of autoimmune disorders
• Supportive treatment in infectious diseases

Dosage

Children: Paediatric dosing must be determined based on the specific humanum product and the clinical context. Refer to specific product guidelines for appropriate dosing.

Adults: Dosage varies widely based on the specific humanum product and condition being treated. Refer to specific product guidelines for appropriate dosing.

Mechanism of action

Humanum products typically function through various mechanisms depending on their specific type. For example, monoclonal antibodies may target specific antigens on pathogens or diseased cells, leading to their destruction by the immune system. Hormonal preparations may interact with specific receptors to restore normal physiological function. The precise pathway will vary based on the specific humanum product and its intended use.

Pharmacodynamics

The pharmacodynamics of humanum products involves the interaction between the drug and the immune system or target cells. These preparations can enhance or inhibit biological processes, leading to therapeutic effects such as increased immune response, modulation of inflammatory pathways, or restoration of normal biological functions. The effects are often dose-dependent and may vary between individuals based on their unique immune profiles.

Pharmacokinetics

Pharmacokinetics of humanum products is diverse and depends on the formulation and route of administration. Generally, these products may have varying absorption rates, half-lives, and distribution characteristics. For example, monoclonal antibodies are usually administered intravenously and may have a longer half-life due to their size and the presence of Fc receptors that prolong their circulation. Metabolism is commonly mediated by proteolytic enzymes, and excretion often occurs via the reticuloendothelial system or through renal pathways.

Pregnancy

The safety of humanum during pregnancy has not been established. Consider potential benefits against risks.

Breast-feeding

Caution is advised when using humanum during breastfeeding. Monitor for possible adverse effects in infants.

Storage

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Type 1 diabetes mellitus
• Type 2 diabetes mellitus
• Gestational diabetes
• Diabetic ketoacidosis
• Hyperglycemia in critically ill patients

Dosage

Children: Dosing for paediatric patients should be individualized based on the child's age, weight, and specific needs. Refer to the BNF for Children for detailed dosing guidelines.

Adults: Dosage of insulin varies widely based on individual needs, blood glucose levels, and the specific type of insulin used. It is essential to tailor insulin therapy to the patient's requirements and to refer to established guidelines for dosing.

Mechanism of action

Insulin acts by binding to the insulin receptor, a transmembrane receptor that initiates a signaling cascade involving the translocation of glucose transporter type 4 (GLUT4) to the cell membrane. This process enhances glucose uptake by tissues, lowers blood glucose levels, and promotes glycogen synthesis and storage. Insulin also inhibits gluconeogenesis and lipolysis, contributing to its role in glucose homeostasis.

Pharmacodynamics

Insulin's pharmacodynamic effects include the reduction of blood glucose levels, promotion of glycogen storage in the liver and muscle, enhancement of protein synthesis, and inhibition of lipolysis. The onset of action varies depending on the formulation, with rapid-acting insulins acting within minutes and long-acting insulins providing a sustained effect for several hours.

Pharmacokinetics

Insulin is administered via subcutaneous injection, as it is inactivated by the gastrointestinal tract when taken orally. The absorption rate varies by injection site and formulation. The half-life of insulin in circulation is about 4 to 6 minutes, but its effects can last longer due to ongoing actions in target tissues. Metabolism primarily occurs in the liver and kidneys, with excretion occurring through the urine.

Contra-indications

• Hypoglycaemia
• Allergy to insulin or any of its excipients

Adverse effects

• Hypoglycaemia
• Weight gain
• Injection site reactions (redness, swelling, itching)
• Lipodystrophy (localized fat loss or accumulation at injection sites)
• Allergic reactions (rare)

Interactions

• Corticosteroids may increase insulin resistance, requiring higher doses of insulin
• Oral hypoglycaemics may enhance the effects of insulin
• Alcohol can potentiate hypoglycaemic effects
• Beta-blockers may mask symptoms of hypoglycaemia

Precautions

• Monitor blood glucose levels regularly
• Adjust doses during illness, stress, or changes in physical activity
• Educate patients on recognizing hypoglycaemic symptoms
• Use with caution in patients with renal or hepatic impairment

Pregnancy

Insulin is generally considered safe for use during pregnancy, with careful monitoring and dose adjustments as necessary.

Breast-feeding

Insulin is compatible with breastfeeding; however, monitoring of blood glucose is recommended.

Storage

Store unopened vials or pens in a refrigerator (2-8°C). Once opened, insulin can be stored at room temperature (below 30°C) for up to 28 days. Avoid freezing.

Formulations

• Rapid-acting insulin (e.g., insulin lispro, insulin aspart)
• Short-acting insulin (e.g., regular insulin)
• Intermediate-acting insulin (e.g., NPH insulin)
• Long-acting insulin (e.g., insulin glargine, insulin detemir)
• Premixed insulin formulations